Business Segments · Total Costs & Expenses
Pharmaceutical and Specialty Solutions — Total Costs & Expenses
Cardinal Health Pharmaceutical and Specialty Solutions — Total Costs & Expenses decreased by 7.8% to $55.33B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 11.2%, from $49.77B to $55.33B. Over 2 years (FY 2023 to FY 2025), Pharmaceutical and Specialty Solutions — Total Costs & Expenses shows relatively stable performance with a 4.1% CAGR. This is a positive signal — lower values indicate better performance for this metric.
Analysis
StatementSegment
CategoryEfficiency
SignalLower is better
VolatilityStable
First reportedQ3 2022
Last reportedQ1 2026
Rolls up toTotal Operating Expenses
How to read this metric
Rising costs without proportional revenue growth indicate declining operational efficiency.
Detailed definition
The aggregate of all costs, including cost of products sold and distribution, selling, general, and administrative expen...
Peer comparison
Standard aggregate expense metric for segment-level financial reporting.
Metric ID:
cah_segment_pharmaceutical_and_specialty_solutions_costs_and_expensesHistorical Data
15 periods
| Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $46.73B | $46.73B | $46.73B | $46.73B | $52.00B | $52.00B | $52.00B | $52.00B | $47.46B | $50.32B | $49.77B | $54.84B | $58.54B | $59.98B | $55.33B |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +11.3% | +0.0% | +0.0% | +0.0% | -8.7% | +6.0% | -1.1% | +10.2% | +6.7% | +2.5% | -7.8% |
| YoY Change | — | — | — | — | +11.3% | +11.3% | +11.3% | +11.3% | -8.7% | -3.2% | -4.3% | +5.5% | +23.3% | +19.2% | +11.2% |
Range$46.73B – $59.98B
CAGR+4.9%
Avg YoY Growth+8.0%
Median YoY Growth+11.3%
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Cardinal Health's pharmaceutical and specialty solutions — total costs & expenses?
- Cardinal Health (CAH) reported pharmaceutical and specialty solutions — total costs & expenses of $55.33B in Q1 2026.
- How has Cardinal Health's pharmaceutical and specialty solutions — total costs & expenses changed year-over-year?
- Cardinal Health's pharmaceutical and specialty solutions — total costs & expenses increased by 11.2% year-over-year, from $49.77B to $55.33B.
- What is the long-term trend for Cardinal Health's pharmaceutical and specialty solutions — total costs & expenses?
- Over 2 years (2023 to 2025), Cardinal Health's pharmaceutical and specialty solutions — total costs & expenses has grown at a 4.1% compound annual growth rate (CAGR), from $186.93B to $202.39B.
- What does pharmaceutical and specialty solutions — total costs & expenses mean?
- The total sum of all operating costs and expenses for the pharmaceutical segment.